Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...
A research-supported myofascial release system developed from Dr. Jacobs’ clinical practice and personal healing journey ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and ...
UC San Diego leads a $25.8 million ARPA-H funded project to 3D bioprint patient-specific human livers, aiming to eliminate organ shortages.
News Medical on MSN
ARPA-H Project Awarded at UC San Diego Aims to End Liver Transplant Shortage with 3D Bioprinting
The goals of this project represent the culmination of more than two decades of 3D bioprinting innovation by Chen and his lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback